In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Mariia LarkinaDepartment of Pharmaceutical Analysis, Siberian State Medical University, Moscow Tract, 2, 634050 Tomsk, Russia.ORCID 0000-0003-1176-2441 Anastasia DeminaDepartment of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, Vernadsky Ave., 86, 119571 Moscow, Russia.ORCID 0009-0009-6059-6786 Nikita SuvorovDepartment of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, Vernadsky Ave., 86, 119571 Moscow, Russia.ORCID 0000-0002-2749-3656 Petr OstroverkhovDepartment of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, Vernadsky Ave., 86, 119571 Moscow, Russia.ORCID 0000-0001-5778-4510 Evgenii PlotnikovResearch Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Lenin Ave., 30, 634050 Tomsk, Russia.ORCID 0000-0002-4374-6422 Ruslan VarvashenyaResearch Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Lenin Ave., 30, 634050 Tomsk, Russia.ORCID 0009-0002-4282-3198 Vitalina BodenkoResearch Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Lenin Ave., 30, 634050 Tomsk, Russia.ORCID 0000-0001-5097-9737 Gleb YanovichDepartment of Pharmaceutical Analysis, Siberian State Medical University, Moscow Tract, 2, 634050 Tomsk, Russia.
Anastasia PrachResearch Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Lenin Ave., 30, 634050 Tomsk, Russia.ORCID 0000-0002-6975-2361 Viktor PogorilyyDepartment of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, Vernadsky Ave., 86, 119571 Moscow, Russia.ORCID 0000-0003-3556-8600 Sergey TikhonovDepartment of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, Vernadsky Ave., 86, 119571 Moscow, Russia.ORCID 0000-0001-8262-3380 Alexander PopovDepartment of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, Vernadsky Ave., 86, 119571 Moscow, Russia.ORCID 0000-0002-5622-5300 Maxim UsachevDepartment of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, Vernadsky Ave., 86, 119571 Moscow, Russia.
Beatrice VolelN.V. Sklifosovskyi Institute of Clinical Medicine, Rossolimo St., 11, Bld. 2, 119435 Moscow, Russia.ORCID 0000-0003-1667-5355 Yuriy Vasil'evDepartment of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, Vernadsky Ave., 86, 119571 Moscow, Russia.ORCID 0000-0003-3541-6068 Mikhail BelousovDepartment of Pharmaceutical Analysis, Siberian State Medical University, Moscow Tract, 2, 634050 Tomsk, Russia.ORCID 0000-0002-2153-7945 Mikhail GrinDepartment of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, Vernadsky Ave., 86, 119571 Moscow, Russia.
Funding
Ministry of Science and Higher Education of the Russian Federation FSFZ-2025-0020
6 · The paper itselfAbstract
Radionuclide-based molecular imaging modalities are active and developing areas of functional and molecular diagnosis. Among the radionuclides used for SPECT imaging in oncology,
Indexed as
cancerchlorinDTPAiminodiacetic acidradiopharmaceuticalstechnetium-99m
Identifiers
PMID41599130
PMCPMC12844883
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390